Adult stem cells

Issues in Law and Medicine

Volumn 19, Issue 3, 2004, Pages 265-294

  Prentice, David A ^a  

^a INDIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BONE MORPHOGENETIC PROTEIN 2; CELL MARKER; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE TISSUE CELL; AMNION CELL; BIOENGINEERING; BIOTECHNOLOGY; BONE DEFECT; BREAST CELL; CARTILAGE; CELL ACTIVITY; CELL REGENERATION; CELL STIMULATION; CORNEA LIMBUS; EMBRYONAL CARCINOMA; GENE EXPRESSION; GENE THERAPY; HEART; HEMATOPOIETIC STEM CELL; HUMAN; LIVER CELL; MEDICAL RESEARCH; MESENCHYME CELL; MOLECULAR DYNAMICS; MUSCLE CELL; NERVE CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PANCREAS CELL; PARKINSON DISEASE; PERIPHERAL BLOOD STEM CELL; PROTEIN EXPRESSION; REVIEW; SALIVARY GLAND; SKIN; SPINAL CORD INJURY; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SYNOVIUM; TENDON; THYMOCYTE; TISSUE REPAIR; TOOTH PULP; UMBILICAL CORD BLOOD; ADULT; ANIMAL; BIOMEDICAL AND BEHAVIORAL RESEARCH; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; GENETIC ENGINEERING; METABOLISM; PHYSIOLOGY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ADULT; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELLS; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 2442599319     PISSN: 87568160     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (243)

1. a. Mangi AA et al., "Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts," Nature Medicine 9, 1195-1201, Sept 2003.
2. b. Britten MB et al., "Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction," Circulation 108, 2212-2218, Nov 2003.
3. c. Urbanek K et al., "Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy," Proceedings of the National Academy of Sciences USA 100, 10440-10445, 2 Sept 2003; Beltrami AP et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration," Cell 114, 763-776, 19 Sept 2003; Oh H et al., "Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction," Proceedings of the National Academy of Sciences USA 100, 12313-12318, 14 Oct 2003.
4. c. Urbanek K et al., "Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy," Proceedings of the National Academy of Sciences USA 100, 10440-10445, 2 Sept 2003; Beltrami AP et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration," Cell 114, 763-776, 19 Sept 2003; Oh H et al., "Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction," Proceedings of the National Academy of Sciences USA 100, 12313-12318, 14 Oct 2003.
5. c. Urbanek K et al., "Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy," Proceedings of the National Academy of Sciences USA 100, 10440-10445, 2 Sept 2003; Beltrami AP et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration," Cell 114, 763-776, 19 Sept 2003; Oh H et al., "Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction," Proceedings of the National Academy of Sciences USA 100, 12313-12318, 14 Oct 2003.
6. d. Jeong S-W et al., "Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage," Stroke 34, 2258-2263, Sept 2003.
7. e. Xin L et al., "In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme," Proceedings of the National Academy of Sciences USA 100, 11896-11903, 30 Sept 2003.
8. f. Suratt BT et al., "Human pulmonary chimerism after hematopoietic stem cell transplantation," American Journal of Respiratory and Critical Care Medicine 168, 318-322, 2003.
9. g. Li H et al., "Pluripotent stem cells from the adult mouse inner ear," Nature Medicine 9, 1293-1299, Oct 2003.
10. h. Li FX et al., "The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss," Proceedings of the National Academy of Sciences USA 100, 12935-12940, 28 Oct 2003.
11. See, for example: Feasel AM et al., "Complete remission of scleromyxedema following autologous stem cell transplantation," Archives of Dermatology 137, 1071-1072; Aug 2001; Mancardi GL et al.; "Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS; Neurology 57, 62-68; 10 July 2001; Traynor AE et al, "Hematopoietic stem cell transplantation for severe and refractory lupus, Arthritis Rheumatology 46, 2917-2923; November 2002; Wulffraat NM et al.; "Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus, Arthritis Rheumatology 44, 728-731; March 2001; Burt RK et al., "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease," Blood 101, 2064-2066; 2003.
12. See, for example: Feasel AM et al., "Complete remission of scleromyxedema following autologous stem cell transplantation," Archives of Dermatology 137, 1071-1072; Aug 2001; Mancardi GL et al.; "Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS; Neurology 57, 62-68; 10 July 2001; Traynor AE et al, "Hematopoietic stem cell transplantation for severe and refractory lupus, Arthritis Rheumatology 46, 2917-2923; November 2002; Wulffraat NM et al.; "Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus, Arthritis Rheumatology 44, 728-731; March 2001; Burt RK et al., "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease," Blood 101, 2064-2066; 2003.
13. See, for example: Feasel AM et al., "Complete remission of scleromyxedema following autologous stem cell transplantation," Archives of Dermatology 137, 1071-1072; Aug 2001; Mancardi GL et al.; "Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS; Neurology 57, 62-68; 10 July 2001; Traynor AE et al, "Hematopoietic stem cell transplantation for severe and refractory lupus, Arthritis Rheumatology 46, 2917-2923; November 2002; Wulffraat NM et al.; "Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus, Arthritis Rheumatology 44, 728-731; March 2001; Burt RK et al., "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease," Blood 101, 2064-2066; 2003.
14. See, for example: Feasel AM et al., "Complete remission of scleromyxedema following autologous stem cell transplantation," Archives of Dermatology 137, 1071-1072; Aug 2001; Mancardi GL et al.; "Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS; Neurology 57, 62-68; 10 July 2001; Traynor AE et al, "Hematopoietic stem cell transplantation for severe and refractory lupus, Arthritis Rheumatology 46, 2917-2923; November 2002; Wulffraat NM et al.; "Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus, Arthritis Rheumatology 44, 728-731; March 2001; Burt RK et al., "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease," Blood 101, 2064-2066; 2003.
15. See, for example: Feasel AM et al., "Complete remission of scleromyxedema following autologous stem cell transplantation," Archives of Dermatology 137, 1071-1072; Aug 2001; Mancardi GL et al.; "Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS; Neurology 57, 62-68; 10 July 2001; Traynor AE et al, "Hematopoietic stem cell transplantation for severe and refractory lupus, Arthritis Rheumatology 46, 2917-2923; November 2002; Wulffraat NM et al.; "Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus, Arthritis Rheumatology 44, 728-731; March 2001; Burt RK et al., "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease," Blood 101, 2064-2066; 2003.
16. Jiang Y et al., "Pluripotency of mesenchymal stem cells derived from adult marrow," Nature 418, 41-49; 4 July 2002.
17. Yu Y et al., "AC133-2, a novel isoform of human AC133 stem cell antigen," Journal of Biological Chemistry 277, 20711-20716, 7 June 2002.
18. Danet GH et al., "C1qRp defines a new human stem cell population with hematopoietic and hepatic potential," Proceedings of the National Academy of Sciences USA 99, 10441-10445, 6 Aug 2002.
19. Zhou S et al., "The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype," Nature Medicine 7, 1028-1034, Sept 2001.
20. Tremain N et al., "MicroSAGE Analysis of 2,353 Expressed Genes in a Single Cell derived Colony of Undifferentiated Human Mesenchymal Stem Cells Reveals mRNAs of Multiple Cell Lineages," Stem Cells 19, 408-418, 2001.
21. Wright LS et al., "Gene expression in human neural stem cells: effects of leukemia inhibitory factor," Journal of Neurochemistry, 86, 179-195, July 2003.
22. Ivanova NB et al., "A stem cell molecular signature," Science 298, 601-604, 18 Oct 2002; Ramalho-Santos M et al., Stemness: Transcriptional profiling of embryonic and adult stem cells," Science 298, 597-600, 18 Oct 2002.
23. Ivanova NB et al., "A stem cell molecular signature," Science 298, 601-604, 18 Oct 2002; Ramalho-Santos M et al., Stemness: Transcriptional profiling of embryonic and adult stem cells," Science 298, 597-600, 18 Oct 2002.
24. Dao MA et al., "Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution," Blood 101, 112-118, 1 Jan 2003; Handgretinger R et al., "Biology and plasticity of CD133+ hematopoietic stem cells," Annals of the New York Academy of Sciences 996, 141-151, 2003; Huss R et al., "Evidence of peripheral blood-derived, plastic-adherent CD34-/low hematopoietic stem cell clones with mesenchymal stem cell characteristics," Stem Cells 18, 252-260, 2000; Huss R. "Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources," Stem Cells 18, 1-9, 2000.
25. Dao MA et al., "Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution," Blood 101, 112-118, 1 Jan 2003; Handgretinger R et al., "Biology and plasticity of CD133+ hematopoietic stem cells," Annals of the New York Academy of Sciences 996, 141-151, 2003; Huss R et al., "Evidence of peripheral blood-derived, plastic-adherent CD34-/low hematopoietic stem cell clones with mesenchymal stem cell characteristics," Stem Cells 18, 252-260, 2000; Huss R. "Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources," Stem Cells 18, 1-9, 2000.
26. Dao MA et al., "Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution," Blood 101, 112-118, 1 Jan 2003; Handgretinger R et al., "Biology and plasticity of CD133+ hematopoietic stem cells," Annals of the New York Academy of Sciences 996, 141-151, 2003; Huss R et al., "Evidence of peripheral blood-derived, plastic-adherent CD34-/low hematopoietic stem cell clones with mesenchymal stem cell characteristics," Stem Cells 18, 252-260, 2000; Huss R. "Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources," Stem Cells 18, 1-9, 2000.
27. Dao MA et al., "Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution," Blood 101, 112-118, 1 Jan 2003; Handgretinger R et al., "Biology and plasticity of CD133+ hematopoietic stem cells," Annals of the New York Academy of Sciences 996, 141-151, 2003; Huss R et al., "Evidence of peripheral blood-derived, plastic-adherent CD34-/low hematopoietic stem cell clones with mesenchymal stem cell characteristics," Stem Cells 18, 252-260, 2000; Huss R. "Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources," Stem Cells 18, 1-9, 2000.
28. Lodie TA et al., "Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction," Tissue Engineering 8, 739-751, 2002.
29. Tagami M et al., "Genetic and ultrastructural demonstration of strong reversibility in human mesenchymal stem cell," Cell and Tissue Research 312, 31-40, Apr 2003.
30. Theise ND and Krause DS, "Suggestions for a New Paradigm of Cell Differentiative Potential," Blood Cells, Molecules, and Diseases 27, 625-631, 2001; Thiese ND and Krause DS, "Toward a new paradigm of cell plasticity," Leukemia 16, 542-548, 2002.
31. Theise ND and Krause DS, "Suggestions for a New Paradigm of Cell Differentiative Potential," Blood Cells, Molecules, and Diseases 27, 625-631, 2001; Thiese ND and Krause DS, "Toward a new paradigm of cell plasticity," Leukemia 16, 542-548, 2002.
32. Blau HM et al., "The evolving concept of a stem cell: entity or function?" Cell 105, 829-841, 29 June 2001.
33. Tsai RYL and McKay RDG, "Cell Contact Regulates Fate Choice by Cortical Stem Cells," Journal of Neuroscience 20, 3725-3735, May 2000.
34. Wagers AJ et al., "Little evidence for developmental plasticity of adult hematopoietic stem cells," Science 297, 2256-2259, 27 Sept 2002.
35. Krause DS et al., "Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell," Cell 105, 369-377, 4 May 2001.
36. Castro RF et al., "Failure of bone marrow cells to transdifferentiate into neural cells in vivo," Science 297, 1299, 23 Aug 2002.
37. Brazelton, TR et al., "From marrow to brain: expression of neuronal phenotypes in adult mice," Science 290, 1775-1779, 1 Dec 2000.
38. Moore BE and Quesenberry PJ, "The adult hemopoietic stem cell plasticity debate: idols vs new paradigms," Leukemia 17, 1205-1210, 2003.
39. Alison MR et al., "Plastic adult stem cells: will they graduate from the school of hard knocks?" Journal of Cell Science 116, 599-603, 2003.
40. Tada M et al., "Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells," Current Biology 11, 1553-1558, 2 Oct 2001; Terada N et al., "Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion," Nature 416, 542-545, 4 Apr 2002; Ying Q-L et al., "Changing potency by spontaneous fusion," Nature 545-548, 4 Apr 2002; Tada M et al., "Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells," EMBO Journal 16, 6510-6520, 1997.
41. Tada M et al., "Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells," Current Biology 11, 1553-1558, 2 Oct 2001; Terada N et al., "Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion," Nature 416, 542-545, 4 Apr 2002; Ying Q-L et al., "Changing potency by spontaneous fusion," Nature 545-548, 4 Apr 2002; Tada M et al., "Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells," EMBO Journal 16, 6510-6520, 1997.
42. Tada M et al., "Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells," Current Biology 11, 1553-1558, 2 Oct 2001; Terada N et al., "Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion," Nature 416, 542-545, 4 Apr 2002; Ying Q-L et al., "Changing potency by spontaneous fusion," Nature 545-548, 4 Apr 2002; Tada M et al., "Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells," EMBO Journal 16, 6510-6520, 1997.
43. Tada M et al., "Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells," Current Biology 11, 1553-1558, 2 Oct 2001; Terada N et al., "Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion," Nature 416, 542-545, 4 Apr 2002; Ying Q-L et al., "Changing potency by spontaneous fusion," Nature 545-548, 4 Apr 2002; Tada M et al., "Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells," EMBO Journal 16, 6510-6520, 1997.
44. See, for example: Sorieul S and Ephrussi B, "Karyological demonstration of hybridization of mammalian cells in vitro," Nature 190, 653-654, 1961; Littlefield JW "Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants," Science 145, 709-710, 14 Aug 1964; Weiss MC and Green H, "Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes," Proceedings oj the National Academy of Sciences USA 58, 1104-1111, Sept 1967; Ladda RL and Estensen RD, "Introduction of a heterologous nucleus into enucleated cytoplasms of cultured mouse L-cells," Proceedings of the National Academy of Sciences USA 67, 1528-1533, Nov 1970; Köhler G Milstein C, "Continuous culture of fused cells secreting antibody of predefined specificity," Nature 256, 495-497, 1975.
45. See, for example: Sorieul S and Ephrussi B, "Karyological demonstration of hybridization of mammalian cells in vitro," Nature 190, 653-654, 1961; Littlefield JW "Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants," Science 145, 709-710, 14 Aug 1964; Weiss MC and Green H, "Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes," Proceedings oj the National Academy of Sciences USA 58, 1104-1111, Sept 1967; Ladda RL and Estensen RD, "Introduction of a heterologous nucleus into enucleated cytoplasms of cultured mouse L-cells," Proceedings of the National Academy of Sciences USA 67, 1528-1533, Nov 1970; Köhler G Milstein C, "Continuous culture of fused cells secreting antibody of predefined specificity," Nature 256, 495-497, 1975.
46. See, for example: Sorieul S and Ephrussi B, "Karyological demonstration of hybridization of mammalian cells in vitro," Nature 190, 653-654, 1961; Littlefield JW "Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants," Science 145, 709-710, 14 Aug 1964; Weiss MC and Green H, "Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes," Proceedings oj the National Academy of Sciences USA 58, 1104-1111, Sept 1967; Ladda RL and Estensen RD, "Introduction of a heterologous nucleus into enucleated cytoplasms of cultured mouse L-cells," Proceedings of the National Academy of Sciences USA 67, 1528-1533, Nov 1970; Köhler G Milstein C, "Continuous culture of fused cells secreting antibody of predefined specificity," Nature 256, 495-497, 1975.
47. See, for example: Sorieul S and Ephrussi B, "Karyological demonstration of hybridization of mammalian cells in vitro," Nature 190, 653-654, 1961; Littlefield JW "Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants," Science 145, 709-710, 14 Aug 1964; Weiss MC and Green H, "Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes," Proceedings oj the National Academy of Sciences USA 58, 1104-1111, Sept 1967; Ladda RL and Estensen RD, "Introduction of a heterologous nucleus into enucleated cytoplasms of cultured mouse L-cells," Proceedings of the National Academy of Sciences USA 67, 1528-1533, Nov 1970; Köhler G Milstein C, "Continuous culture of fused cells secreting antibody of predefined specificity," Nature 256, 495-497, 1975.
48. See, for example: Sorieul S and Ephrussi B, "Karyological demonstration of hybridization of mammalian cells in vitro," Nature 190, 653-654, 1961; Littlefield JW "Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants," Science 145, 709-710, 14 Aug 1964; Weiss MC and Green H, "Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes," Proceedings oj the National Academy of Sciences USA 58, 1104-1111, Sept 1967; Ladda RL and Estensen RD, "Introduction of a heterologous nucleus into enucleated cytoplasms of cultured mouse L-cells," Proceedings of the National Academy of Sciences USA 67, 1528-1533, Nov 1970; Köhler G Milstein C, "Continuous culture of fused cells secreting antibody of predefined specificity," Nature 256, 495-497, 1975.
49. Wang X et al., "Cell fusion is the principal source of bone-marrow-derived hepatocytes," Nature 422, 897-901, 24 April 2003; Vassilopoulos G et al., "Transplanted bone marrow regenerates liver by cell fusion," Nature 422, 901-904, 24 April 2003.
50. Wang X et al., "Cell fusion is the principal source of bone-marrow-derived hepatocytes," Nature 422, 897-901, 24 April 2003; Vassilopoulos G et al., "Transplanted bone marrow regenerates liver by cell fusion," Nature 422, 901-904, 24 April 2003.
51. Spees JL et al., "Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma," Proceedings of the National Academy of Sciences USA 100, 2397-2402, 4 Mar 2003.
52. Blau HM, "Stem-cell fusion: A twist of fate," Nature 419, 437, 3 Oct 2002.
53. Collas P and Håkelien A-M, "Reprogramming Somatic Cells for Therapeutic Applications," Journal of Regenerative Medicine 4, 7-13, February 2003; Håkelien AM et al, "Reprogramming fibroblasts to express T-cell functions using cell extracts," Nature Biotechnology 20, 460-466, May 2002; Håkelien AM and Collas P, "Novel approaches to transdifferentiation," Cloning and Stem Cells 4, 379-387, 2002.
54. Collas P and Håkelien A-M, "Reprogramming Somatic Cells for Therapeutic Applications," Journal of Regenerative Medicine 4, 7-13, February 2003; Håkelien AM et al, "Reprogramming fibroblasts to express T-cell functions using cell extracts," Nature Biotechnology 20, 460-466, May 2002; Håkelien AM and Collas P, "Novel approaches to transdifferentiation," Cloning and Stem Cells 4, 379-387, 2002.
55. Collas P and Håkelien A-M, "Reprogramming Somatic Cells for Therapeutic Applications," Journal of Regenerative Medicine 4, 7-13, February 2003; Håkelien AM et al, "Reprogramming fibroblasts to express T-cell functions using cell extracts," Nature Biotechnology 20, 460-466, May 2002; Håkelien AM and Collas P, "Novel approaches to transdifferentiation," Cloning and Stem Cells 4, 379-387, 2002.
56. Tran SD et al., "Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study," Lancet 361, 1084-1088, 29 March 2003.
57. Newsome PN et al., "Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion," Gastroenterology 124, 1891-1900, June 2003.
58. Mazurier F et al., "Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells," Nature Medicine 9, 959-963, July 2003.
59. Bianco P et al., "Bone marrow stromal stem cells: nature, biology, and potential applications," Stem Cells 19, 180-192, 2001.
60. Sanchez-Ramos J et al., "Adult bone marrow stromal cells differentiate into neural cells in vitro," Experimental Neurology 164, 247-256, 2000.
61. Woodbury D et al., "Adult rat and human bone marrow stromal cells differentiate intoneurons," Journal of Neuroscience Research 61, 364-370, 2000.
62. Pittenger MF et al., "Multilineage potential of adult human mesenchymal stem cells," Science 284, 143-147, 2 Apr 1999.
63. Gronthos S et al., "Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow," Journal of Cell Science 116, 1827-1835, 2003.
64. Woodbury D et al., "Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis," Journal of Neuroscience Research 96, 908-917, 2002.
65. Koc ON et al., "Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)," Bone Marrow Transplant 215-222, Aug 2002.
66. Mezey, E et al., "Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow;" Science 290, 1779-1782, 1 Dec 2000.
67. Kabos P et al., "Generation of neural progenitor cells from whole adult bone marrow," Experimental Neurology 178, 288-293, December 2002.
68. Körbling MK et al., "Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells," New England Journal of Medicine 346, 738-746, 7 March 2002.
69. Mezey E et al., "Transplanted bone marrow generates new neurons in human brains," Proceedings of the National Academy of Sciences USA 100, 1364-1369, 4 Feb 2003.
70. Priller J et al., "Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo," Journal of Cell Biology 155, 733-738, 26 Nov 2001.
71. Weimann JM et al., "Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains," Proceedings of the National Academy of Sciences USA 100, 2088-2093, 18 Feb 2003.
72. Hess DC et al., "Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke," Stroke 33, 1362-1368, May 2002.
73. Chen J et al., "Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats," Stroke 32, 1005-1011, April 2001.
74. Li Y et al., "Human marrow stromal cell therapy for stroke in rat," Neurology 59, 514-523, August 2002.
75. Heissig B et al., "Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand," Cell 109, 625-637, 31 May 2002.
76. Otani A et al., "Bone marrow derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis," Nature Medicine 8, 1004-1010, Sept 2002.
77. Tomita M et al., "Bone marrow derived stem cells can differentiate into retinal cells in injured rat retina," Stem Cells 20, 279-283, 2002.
78. Sasaki M et al., "Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons," Glia 35, 26-34, July 2001.
79. Hofstetter CP et al., "Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery," Proceedings of the National Academy of Sciences USA 99, 2199-2204, 19 February 2002.
80. Sekiya I et al., "In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis," Proceedings of the National Academy of Sciences USA 99, 4397-4402, 2 Apr 2002.
81. Ferrari G et al., "Muscle regeneration by bone marrow-derived myogenic progenitors," Science 279, 1528-1530, Mar 6, 1998.
82. LaBarge MA and Blau HM, "Biological progression from adult bone marrow to multinucleate muscle fiber in response to injury" Cell 111, 589-601, 15 November 2002.
83. Gussoni E. et al., "Long term persistence of donor nuclei in a Duchenne Muscular dystrophy patient receiving bone marrow transplantation," Journal of Clinical Investigation 110, 807-814, Sept 2002.
84. Ito T et al., "Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling," Journal of the American Society of Nephrology 12, 2625-2635, 2001.
85. Masuya M et al., "Hematopoietic origin of glomerular mesangial cells," Blood 101, 2215-2218, 15 March 2003.
86. Kale S et al., "Bone marrow stem cells contribute to repair of the ischemically injured renal tubule," Journal of Clinical Investigation 112, 42-49, July 2003.
87. Lin F et al., "Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice," Journal of the American Society of Nephrology 14, 1188-1199, 2003.
88. Poulsom R et al., "Bone marrow stem cells contribute to healing of the kidney," Journal of the American Society of Nephrology 14, S48-S54, 2003.
89. Miyazaki M et al., "Improved conditions to induce hepatocytes from rat bone marrow cells in culture," Biochemical and Biophysical Research Reports 298, 24-30, October 2002.
90. Fiegel HC et al., "Liver-specific gene expression in cultured human hematopoietic stem cells," Stem Cells 21, 98-104, 2003.
91. Lagasse et al., "Purified hematopoietic stem cells can differentiate into hepatocytes in vivo," Nature Medicine 6, 1229-1234, November 2000.
92. Theise, N et al., "Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation," Hepatology 31, 235-240, Jan. 2000.
93. Theise, N et al., "Liver from bone marrow in humans," Hepatology 32, 11-16, July 2000; Alison, M et al., "Cell differentiation: hepatocytes from non-hepatic adult stem cells," Nature 406, 257, 20 July 2000.
94. Theise, N et al., "Liver from bone marrow in humans," Hepatology 32, 11-16, July 2000; Alison, M et al., "Cell differentiation: hepatocytes from non-hepatic adult stem cells," Nature 406, 257, 20 July 2000.
95. Wang X et al., "Kinetics of liver repopulation after bone marrow transplantation," American Journal of Pathology 161, 565-574, Aug 2002.
96. Wulf GG et al., "Cells of the hepatic side population contribute to liver regeneration and can be replenished by bone marrow stem cells," Haematologica 88, 368-378, 2003.
97. Ianus A et al., "In vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusion," Journal of Clinical Investigation 111, 843-850, March 2003.
98. Hess D et al., "Bone marrow-derived stem cells initiate pancreatic regeneration," Nature Biotechnology 21, 763-770, July 2003.
99. Bittira B et al., "In vitro preprogramming of marrow stromal cells for myocardial regeneration," Annals of Thoracic Surgery 74, 1154-1160, 2002.
100. Orlic D et al., "Bone marrow cells regenerate infarcted myocardium," Nature 410, 701-705, April 5, 2001.
101. Jackson KA et al., "Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells," Journal of Clinical Investigation 107, 1395-1402, June 2001.
102. Orlic D et al., "Mobilized bone marrow cells repair the infarcted heart, improving function and survival," Proceedings of the National Academy of Sciences USA 98, 10344-10349, 28 August 2001.
103. Toma C et al., "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart," Circulation 105, 93-98, 1/8 January 2002.
104. Kocher AA et al., "Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function." Nature Medicine 7, 430-436, April 2001.
105. Edelberg, JM et al., "Young adult bone marrow derived endothelial precursor cells restore aging impaired cardiac angiogenic function," Circulation Research 90, e89-e93, 2002.
106. Saito T et al., "Xenotransplant cardiac chimera: immune tolerance of adult stem cells," Annals of Thoracic Surgery 74, 19-24, 2002.
107. Laflamme MA et al., "Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts," Circulation Research 90, 634-640, 5 Apr 2002.
108. Deb A et al., "Bone marrow-derived cardiomyocytes are present in adult human heart," Circulation 107, 1207-1209, 11 March 2003.
109. Perin EC et al., "Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure," Circulation 107, r75-r83, 2003.
110. Stamm C et al., "Autologous bone-marrow stem-cell transplantation for myocardial regeneration," The Lancet 361, 45-46, 4 Jan 2003.
111. Tse H-F et al., "Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation," The Lancet 361, 47-49, 4 January 2003.
112. Strauer BE et al., "Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans," Circulation 106, 1913-1918, 8 October 2002.
113. Tateishi-Yuyama E et al., "Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial," Lancet 360, 427-435, 10 August 2002.
114. Kotton DN et al., "Bone marrow-derived cells as progenitors of lung alveolar epithelium," Development 128, 5181-5188, December 2001.
115. Ortiz LA et al., "Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects," Proceedings of the National Academy of Sciences USA 100: 8407-8411, 8 July 2003.
116. Okamoto R et al., "Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract," Nature Medicine 8, 1011-1017, Sept 2002.
117. Badiavas EV, "Participation of Bone Marrow Derived Cells in Cutaneous Wound Healing," Journal Of Cellular Physiology 196, 245-250, 2003.
118. Kessinger A, Sharp JG, "The whys and hows of hematopoietic progenitor and stem cell mobilization," Bone Marrow Transplant 31, 319-329, Mar 2003.
119. Willing AE et al., "Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke," Cell Transplantation 12, 449-454, 2003.
120. Borlongan CV and Hess DC, "G-CSF-mobilized human peripheral blood for transplantation therapy in stroke," Cell Transplantation 12, 447-448, 2003.
121. Zhao Y et al., "A human peripheral blood monocyte-derived subset acts as pluripotent stem cells," Proceedings of the National Academy of Sciences USA 100, 2426-2431, 4 March 2003.
122. Abuljadayel IS, "Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood," Current Medical Research and Opinion 19, FastTrack PREPRINT: 355-375, 18 June 2003 (doi: 10.1185/030079903125001901).
123. Pagano SF et al., "Isolation and Characterization of Neural Stem Cells from the Adult Human Olfactory Bulb," Stem Cells 18, 295-300, 2000.
124. Shihabuddin S et al., "Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus," Journal of Neuroscience 20, 8727-8735, December 2000.
125. Palmer TD et al., "Progenitor cells from human brain after death," Nature 411, 42-43, 3 May 2001.
126. Bjornson CRR et al., "Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo," Science 283, 534-537, 22 Jan 1999.
127. Galli R et al., "Neural stem cells: An overview," Circulation Research 92, 598-602, Feb 2003.
128. Clarke DL et al., "Generalized potential of adult neural stem cells," Science 288, 1660-1663, 2 June 2000.
129. Galli R et al., "Skeletal myogenic potential of human and mouse neural stem cells," Nature Neuroscience 3, 986-991, Oct 2000.
130. Rietze RL et al., "Purification of a pluripotent neural stem cell from the adult mouse brain," Nature 412, 736-739, 16 Aug 2001.
131. Englund U et al., "Grafted neural stem cells develop into functional pyramidal neutrons and integrate into host cortical circuitry," Proceedings of the National Academy of Sciences USA 99, 17089-17094, 24 Dec 2002.
132. Arvidsson A et al., "Neuronal replacement from endogenous precursors in the adult brain after stroke," Nature Medicine 8, 963-970, Sept 2002.
133. Riess P et al., Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury," Neurosurgery 51, 1043-1052, Oct 2002.
134. Chang MY et al., "Neurons and astrocytes secrete factors that cause stem cells to differentiate into neurons and astrocytes, respectively," Molecular Cellular Neuroscience 23, 414-426, July 2003.
135. Hori J et al., "Neural progenitor cells lack immunogenicity and resist destruction as allografts," Stem Cells 21, 405-416, 2003; Klassen H et al., "The immunological properties of adult hippocampal progenitor cells," Vision Research 43, 947-956, Apr 2003.
136. Hori J et al., "Neural progenitor cells lack immunogenicity and resist destruction as allografts," Stem Cells 21, 405-416, 2003; Klassen H et al., "The immunological properties of adult hippocampal progenitor cells," Vision Research 43, 947-956, Apr 2003.
137. Pluchino S et al., "Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis," Nature 422, 688-694, 17 April 2003.
138. Liker MA et al., "Human neural stem cell transplantation in the MPTP-lesioned mouse," Brain Research 971, 168-177, May 2003.
139. Kim TE et al., "Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cells," Biochemical and Biophysical Research Communications 305, 1040-1048, 2003.
140. Ourednik J et al., "Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons," Nature Biotechnology 20, 1103-1110, Nov 2002.
141. Åkerud P et al., "Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease," Molecular and Cellular Neuroscience 21, 205-222, Nov 2002.
142. Fallon J et al., "In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain," Proceedings of the National Academy of Sciences USA 97, 14686-14691, 19 December 2000.
143. Gill SS et al., "Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease," Nature Medicine 9, 589-595, May 2003.
144. Lévesque M and Neuman T, "Autologous transplantation of adult human neural stem cells and differentiated dopaminergic neurons for Parkinson disease: 1-year postoperative clinical and functional metabolic result," American Association of Neurological Surgeons annual meeting, Abstract #702, 8 April 2002.
145. Barnett et al., "Identification of a human olfactory ensheathing cell that can effect transplantmediated remyelination of demyelinated CNS axons," Brain 123, 1581-1588, Aug 2000.
146. Ramón-Cueto A et al., "Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia," Neuron 25, 425-435, February 2000.
147. Ramón-Cueto A et al., "Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants," The Journal of Neuroscience 18, 3803-3815, 15 May 1998.
148. Ramer MS et al., "Functional regeneration of sensory axons into the adult spinal cord," Nature 403, 312-316, Jan 20, 2000.
149. Jiang S et al., "Enteric glia promote regeneration of transected dorsal root axons into spinal cord of adult rats," Experimental Neurology 181, 79-83, 2003.
150. Menet V et al., "Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes," Proceedings of the National Academy of Sciences USA 100, 8999-9004, 22 July 2003.
151. Iacovitti L et al., "Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line," Brain Research 912, 99-104, 2001.
152. Garbuzova-Davis S et al., "Positive effect of transplantation of hNT neurons (Ntera 2/D1 cell-line) in a model of familial amyotrophic sclerosis," Experimental Neurology 174, 169-180, Apr 2002; Garbuzova-Davis S et al., "Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit," Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2, 175-180, Dec 2001.
153. Garbuzova-Davis S et al., "Positive effect of transplantation of hNT neurons (Ntera 2/D1 cell-line) in a model of familial amyotrophic sclerosis," Experimental Neurology 174, 169-180, Apr 2002; Garbuzova-Davis S et al., "Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit," Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2, 175-180, Dec 2001.
154. Kondziolka MD et al., "Transplantation of cultured human neuronal cells for patients with stroke," Neurology 55, 565-569, 2000; Meltzer CC et al., "Serial [18F]Fluorodeoxyglucose Positron Emission Tomography after Human Neuronal Implantation for Stroke," Neurosurgery 49, 586-592, 2001; Nelson PT et al., "Clonal human (hNT) neuron grafts for stroke therapy," American Journal of Pathology 160, 1201-1206, Apr 2002.
155. Kondziolka MD et al., "Transplantation of cultured human neuronal cells for patients with stroke," Neurology 55, 565-569, 2000; Meltzer CC et
156. Kondziolka MD et al., "Transplantation of cultured human neuronal cells for patients with stroke," Neurology 55, 565-569, 2000; Meltzer CC et al., "Serial [18F]Fluorodeoxyglucose Positron Emission Tomography after Human Neuronal Implantation for Stroke," Neurosurgery 49, 586-592, 2001; Nelson PT et al., "Clonal human (hNT) neuron grafts for stroke therapy," American Journal of Pathology 160, 1201-1206, Apr 2002.
157. Asakura A et al., "Myogenic specification of side population cells in skeletal muscle," Journal of Cell Biology 159, 123-134, 14 Oct 2002.
158. Lee JY et al., Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing," Journal of Cell Biology 150, 1085-1099, 4 Sept 2000.
159. Torrente Y et al., "Intraarterial injection of muscle-derived CD34+Sca-1+ stem cells restores dystrophin in mdx mice," Journal of Cell Biology 152, 335-348, January 22, 2001.
160. Qu-Petersen Z et al., "Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration," Journal of Cell Biology 157, 851-864, 27 May 2002.
161. Polesskaya A et al., "Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration," Cell 113, 841-852, 27 June 2003.
162. Lee JY et al., "The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence," International Urogynecology Journal of Pelvic Floor Dysfunction 14, 31-37, Feb 2003.
163. Atkins, B et al., "Intracardiac Transplantation of Skeletal Myoblasts Yields Two Populations of Striated Cells In Situ," Annals of Thoracic Surgery 67, 124-129, 1999.
164. Iijima Y et al., "Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes," FASEB Journal 17, 1361-1363; July 2003 (full text Epub 8 May 2003, doi:10.1096/fj.02-1048fje).
165. Menasché P et al., "Myoblast transplantation for heart failure," Lancet 357, 279-280 27 January 2001.
166. Horb ME et al., "Experimental conversion of liver to pancreas," Current Biology, 13, 105-115, 21 Jan 2003.
167. Yang L et al., "In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells," Proceedings of the National Academy of Sciences USA, 99, 8078-8083, 11 June 2002.
168. Malouf, NN et al., "Adult-derived stem cells from the liver become myocytes in the heart in vivo," American Journal of Pathology 158, 1929-1935, June 2001.
169. Wang, X et al., "Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells," American Journal of Pathology 158, 571-579, Feb 2001.
170. Shapiro AMJ et al., "Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen," New England Journal of Medicine 343, 230-238, 27 July 2000; Ryan EA et al., "Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol," Diabetes 50, 710-719, Apr 2001.
171. Shapiro AMJ et al., "Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen," New England Journal of Medicine 343, 230-238, 27 July 2000; Ryan EA et al., "Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol," Diabetes 50, 710-719, Apr 2001.
172. Ramiya VK et al., "Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells," Nature Medicine 6, 278-282, March 2000.
173. Bonner-Weir S et al., "In vitro cultivation of human islets from expanded ductal tissue," Proceedings of the National Academy of Sciences USA 97, 7999-8004, 5 July 2000; Gmyr V et al., "Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: Further evidence for pluripotent pancreatic stem cells in humans," Diabetes 49, 1671-1680, Oct 2000; De la Tour D et al., "Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo," Molecular Endocrinology 15, 476-483, Mar 2001; Abraham et al., "Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells," Endocrinology 143, 3152-3161, August 2002.
174. Bonner-Weir S et al., "In vitro cultivation of human islets from expanded ductal tissue," Proceedings of the National Academy of Sciences USA 97, 7999-8004, 5 July 2000; Gmyr V et al., "Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: Further evidence for pluripotent pancreatic stem cells in humans," Diabetes 49, 1671-1680, Oct 2000; De la Tour D et al., "Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo," Molecular Endocrinology 15, 476-483, Mar 2001; Abraham et al., "Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells," Endocrinology 143, 3152-3161, August 2002.
175. Bonner-Weir S et al., "In vitro cultivation of human islets from expanded ductal tissue," Proceedings of the National Academy of Sciences USA 97, 7999-8004, 5 July 2000; Gmyr V et al., "Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: Further evidence for pluripotent pancreatic stem cells in humans," Diabetes 49, 1671-1680, Oct 2000; De la Tour D et al., "Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo," Molecular Endocrinology 15, 476-483, Mar 2001; Abraham et al., "Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells," Endocrinology 143, 3152-3161, August 2002.
176. Bonner-Weir S et al., "In vitro cultivation of human islets from expanded ductal tissue," Proceedings of the National Academy of Sciences USA 97, 7999-8004, 5 July 2000; Gmyr V et al., "Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: Further evidence for pluripotent pancreatic stem cells in humans," Diabetes 49, 1671-1680, Oct 2000; De la Tour D et al., "Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo," Molecular Endocrinology 15, 476-483, Mar 2001; Abraham et al., "Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells," Endocrinology 143, 3152-3161, August 2002.
177. Suzuki A et al., "Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells," Proceedings of the National Academy of Sciences USA 100, 5034-5039, 29 April 2003.
178. Ferber S et al., "Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozocin induced hyperglycemia," Nature Medicine 6, 568-572, May 2000.
179. Meller D et al., "Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures," British Journal of Ophthalmology 86, 463-471, Apr 2002.
180. Tsai et al., "Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells," New England Journal of Medicine 343, 86-93, 2000; Schwab IR et al., "Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease," Cornea 19, 421-426, July 2000; Tsubota K et al., "Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation, " New England Journal of Medicine 340, 1697-1703, 3 June 1999; Henderson TR et al., "The long term outcome of limbal allografts: the search for surviving cells," British Journal of Ophthalmology 85, 604-609, May 2001.
181. Tsai et al., "Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells," New England Journal of Medicine 343, 86-93, 2000; Schwab IR et al., "Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease," Cornea 19, 421-426, July 2000; Tsubota K et al., "Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation, " New England Journal of Medicine 340, 1697-1703, 3 June 1999; Henderson TR et al., "The long term outcome of limbal allografts: the search for surviving cells," British Journal of Ophthalmology 85, 604-609, May 2001.
182. Tsai et al., "Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells," New England Journal of Medicine 343, 86-93, 2000; Schwab IR et al., "Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease," Cornea 19, 421-426, July 2000; Tsubota K et al., "Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation, " New England Journal of Medicine 340, 1697-1703, 3 June 1999; Henderson TR et al., "The long term outcome of limbal allografts: the search for surviving cells," British Journal of Ophthalmology 85, 604-609, May 2001.
183. Tsai et al., "Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells," New England Journal of Medicine 343, 86-93, 2000; Schwab IR et al., "Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease," Cornea 19, 421-426, July 2000; Tsubota K et al., "Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation, " New England Journal of Medicine 340, 1697-1703, 3 June 1999; Henderson TR et al., "The long term outcome of limbal allografts: the search for surviving cells," British Journal of Ophthalmology 85, 604-609, May 2001.
184. Seigel GM et al., "Human corneal stem cells display functional neuronal properties," Molecular Vision 9, 159-163, 30 Apr 2003.
185. Chacko DM et al., "Transplantation of ocular stem cells: the role of injury in incorporation and differentiation of grafted cells in the retina," Vision Research 43, 937-946, Apr 2003.
186. Dontu G et al., "In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells," Genes and Development 17, 1253-1270, 15 May 2003.
187. Alvi AJ et al., "Functional and molecular characterisation of mammary side population cells," Breast Cancer Research 5, R1-R8, 2003.
188. Okumura K et al., "Salivary gland progenitor cells induced by duct ligation differentiate into hepatic and pancreatic lineages," Hepatology 38, 104-113, July 2003.
189. Toma JG et al., "Isolation of multipotent adult stem cells from the dermis of mammalian skin," Nature Cell Biology 3, 778-784, 3 Sept 2002; Oshima H et al., "Morphogenesis and renewal of hair follicles from adult multipotent stem cells, Cell 104, 233-245, 2001; Taylor G et al., "Involvement of follicular stem cells in forming not only the follicle but also the epidermis," Cell 102, 451-461, 2000.
190. Toma JG et al., "Isolation of multipotent adult stem cells from the dermis of mammalian skin," Nature Cell Biology 3, 778-784, 3 Sept 2002; Oshima H et al., "Morphogenesis and renewal of hair follicles from adult multipotent stem cells, Cell 104, 233-245, 2001; Taylor G et al., "Involvement of follicular stem cells in forming not only the follicle but also the epidermis," Cell 102, 451-461, 2000.
191. Toma JG et al., "Isolation of multipotent adult stem cells from the dermis of mammalian skin," Nature Cell Biology 3, 778-784, 3 Sept 2002; Oshima H et al., "Morphogenesis and renewal of hair follicles from adult multipotent stem cells, Cell 104, 233-245, 2001; Taylor G et al., "Involvement of follicular stem cells in forming not only the follicle but also the epidermis," Cell 102, 451-461, 2000.
192. Lako M et al., "Hair follicle dermal cells repopulate the mouse haematopoietic system," Journal of Cell Science 115, 3967-3974, Sept 2002.
193. Salingcarnboriboon R et al., "Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property," Experimental Cell Research 287, 289-300, 15 July 2003.
194. De Bari C et al., "Multipotent mesenchymal stem cells from adult human synovial membrane," Arthritis Rheumatism 44, 1928-1942, 2001.
195. De Bari C et al., "Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane," Journal of Cell Biology 160, 909-918, 17 March 2003.
196. Beltrami, AP et al., "Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction," New England Journal of Medicine 344, 1750-1757, 7 June 2001.
197. Robinson D et al., "Characteristics of cartilage biopsies used for autologous chondrocytes transplantation," Cell Transplant 10, 203-208, Mar-Apr 2001.
198. Horwitz EM et al., "Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta," Nature Medicine 5, 309-313, 1999.
199. Horwitz EM et al., "Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone," Proceedings of the National Academy of Sciences USA 99, 8932-8937, 25 June 2002.
200. Horwitz EM et al., "Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta," Blood 97, 1227-1231, 1 March 2001.
201. Bennett AR et al., "Identification and characterization of thymic epithelial progenitor cells," Immunity 803-814, June 2002.
202. Gill J et al., "Generation of a complete thymic microenvironment by MTS24+ thymic epithelial cells," Nature Immunology 3, 635-642, 1 Jul 2002.
203. Gronthos S et al., "Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo," Proceedings of the National Academy of Sciences USA 97, 13625-13630, 5 Dec 2000.
204. Miura M et al., "SHED: Stem cells from human exfoliated deciduous teeth," Proceedings of the National Academy of Sciences USA 100, 5807-5812, 13 May 2003.
205. Zuk PA et al., "Multilineage cells from human adipose tissue: implications for cell-based therapies," Tissue Engineering 7, 211-228, 2001; Halvorsen Y-DC et al., "Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells," Tissue Engineering 7, 729-741, 2001; Erickson GR et al., "Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo," Biochemical and Biophysical Research Communications 290, 763-769, 2002.
206. Zuk PA et al., "Multilineage cells from human adipose tissue: implications for cell-based therapies," Tissue Engineering 7, 211-228, 2001; Halvorsen Y-DC et al., "Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells," Tissue Engineering 7, 729-741, 2001; Erickson GR et al., "Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo," Biochemical and Biophysical Research Communications 290, 763-769, 2002.
207. Zuk PA et al., "Multilineage cells from human adipose tissue: implications for cell-based therapies," Tissue Engineering 7, 211-228, 2001; Halvorsen Y-DC et al., "Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells," Tissue Engineering 7, 729-741, 2001; Erickson GR et al., "Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo," Biochemical and Biophysical Research Communications 290, 763-769, 2002.
208. Zuk PA et al., "Human adipose tissue is a source of multipotent stem cells," Molecular Biology of the Cell 13, 4279-4295, Dec 2002; Safford KM et al., "Neurogenic differentiation of murine and human adipose-derived stromal cells," Biochemical and Biophysical Research Communications 294, 371-379, 2002.
209. Zuk PA et al., "Human adipose tissue is a source of multipotent stem cells," Molecular Biology of the Cell 13, 4279-4295, Dec 2002; Safford KM et al., "Neurogenic differentiation of murine and human adipose-derived stromal cells," Biochemical and Biophysical Research Communications 294, 371-379, 2002.
210. See, for example: Kurtzberg J et al., "Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients," New England Journal of Medicine 335, 157-166, 18 July 1996; Laughlin MJ et al., "Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors," New England Journal of Medicine 344, 1815-1822, 14 June 2001;
211. See, for example: Kurtzberg J et al., "Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients," New England Journal of Medicine 335, 157-166, 18 July 1996; Laughlin MJ et al., "Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors," New England Journal of Medicine 344, 1815-1822, 14 June 2001;
212. Gore L et al.; "Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care," Journal of Pediatriatic Hematology and Oncology 22, 437-440, Sep-Oct 2000.
213. Rocha V et al., "Graft-versus-host disease in children who have received a cordblood or bone marrow transplant from an HLA-identical sibling," New England Journal of Medicine, 342, 1846-1854, 22 June 2000.
214. Rainsford E, Reen DJ, "Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation," British Journal of Haematology 116, 702-709, Mar 2002.
215. Beerheide W et al., "Downregulation of β2-microglobulin in human cord blood somatic stem cells after transplantation into livers of SCID-mice: an escape mechanism of stem cells?" Biochemical and Biophysical Research Communications 294, 1052-1063, 2002.
216. Broxmeyer HE et al., "High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years," Proceedings of the National Academy of Sciences USA 100, 645-650, 12 Jan 2003.
217. Sanchez-Ramos J et al., "Expression of neural markers in human umbilical cord blood," Experimental Neurology 171, 109-115, 2001.
218. Chen J et al., "Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats," Stroke 32, 2682-2688, Nov 2001.
219. Saporta S et al., "Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior," Journal of Hematotherapy & Stem Cell Research 12, 271-278, 2003.
220. Garbuzova-Davis S et al., "Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation," Journal of Hematotherapy & Stem Cell Research 12, 255-270, 2003.
221. Buzanska L et al., "Neural stem cell line derived from human umbilical cord blood - morphological and functional properties," Journal of Neurochemistry 85, Suppl 2, 33, June 2003.
222. Kakinuma S et al., "Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells," Stem Cells 21, 217-227, 2003; Ishikawa F et al.; "Transplantied human cord blood cells give rise to hepatocytes in engrafted mice," Annals of the New York Academy of Sciences 996, 174-185, 2003; Wang X et al., "Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells," Blood 101, 4201-4208, 15 May 2003.
223. Kakinuma S et al., "Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells," Stem Cells 21, 217-227, 2003; Ishikawa F et al.; "Transplantied human cord blood cells give rise to hepatocytes in engrafted mice," Annals of the New York Academy of Sciences 996, 174-185, 2003; Wang X et al., "Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells," Blood 101, 4201-4208, 15 May 2003.
224. Kakinuma S et al., "Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells," Stem Cells 21, 217-227, 2003; Ishikawa F et al.; "Transplantied human cord blood cells give rise to hepatocytes in engrafted mice," Annals of the New York Academy of Sciences 996, 174-185, 2003; Wang X et al., "Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells," Blood 101, 4201-4208, 15 May 2003.
225. Mitchell K et al., "Matrix Cells from Wharton's Jelly Form Neurons and Glia," Stem Cells 21, 51-60, 2003.
226. Weiss ML et al., "Transplantation of porcine umbilical cord matrix cells into the rat brain," Experimental Neurology Article in Press, Corrected Proof, available online 11 July 2003.
227. Okawa H et al., "Amniotic epithelial cells transform into neuron-like cells in the ischemic brain," NeuroReport 12, 4003-4007, 2001.
228. Prusa A-R et al., "Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?" Human Reproduction 18, 1489-1493, 2003.
229. Minasi MG et al., "The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues," Development 129, 2773-2783, 2002.
230. Sampaolesi M et al., "Cell therapy of a-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts," Science Published online 10 July 2003 (doi: 10.1126/science.1082254).
231. Jensen GS and Drapeau C, "The use of in situ bone marrow stem cells for the treatment of various degenerative diseases," Medical Hypotheses 59, 422-428, 2002.
232. Grove JE et al., "Marrow-Derived Cells as Vehicles for Delivery of Gene Therapy to Pulmonary Epithelium," Stem Cells, 645-651, July 2002.
233. Steptoe RJ et al., "Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes," Journal of Clinical Investigation 111, 1357-1363, May 2003.
234. McKee JA et al., "Human arteries engineered in vitro," EMBO Reports 4, 633-638, May 2003.
235. Shi S et al., "Bone formation by human postnatal bone marrow stromal cells is enhanced by telomerase expression," Nature Biotechnology 20, 587-591, June 2002; Simonsen JL et al., "Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells," Nature Biotechnology 20, 592-596, June 2002.
236. Shi S et al., "Bone formation by human postnatal bone marrow stromal cells is enhanced by telomerase expression," Nature Biotechnology 20, 587-591, June 2002; Simonsen JL et al., "Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells," Nature Biotechnology 20, 592-596, June 2002.
237. Cavazzana-Calvo M et al., "Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease," Science 288, 669-672, 2000.
238. Hacein-Bey-Abina A et al., "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy," New England Journal of Medicine 346, 1185-1193, 18 Apr 2002.
239. Aiuti A et al., "Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning," Science 296, 2410-2413, 28 June 2002.
240. Benedetti S et al., "Gene therapy of experimental brain tumors using neural progenitor cells," Nature Medicine 6, 447-450, Apr 2000.
241. Jin, HK et al., "Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span," Journal of Clinical Investigation 109, 1183-1191, May 2002.
242. Lee JY et al., "Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice," The Journal of Bone and Joint Surgery 83-A, 1032-1039, July 2001.
243. Zeisberg M et al., "BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury," Nature Medicine 7, 964-968, July 2003.